BIOKÉ and BioSkryb Genomics announce a distribution agreement for the Benelux and Nordic countries

icon.highlightedarticle.dark Management
Last modified: 7 August 2023
A revolution in resolution with ResolveOME
A revolution in resolution with ResolveOME | Photo: BioSkryb
Article image of: BIOKÉ and BioSkryb Genomics announce a distribution agreement for the Benelux and Nordic countries
The ResolveDNA Whole Genome Sequencing Workflow | Photo: BioSkryb

BIOKÉ, a leading distributor of life science technologies throughout Europe, has partnered with BioSkryb Genomics (BioSkryb), a pioneer in comprehensive single-cell multiomic research solutions, to distribute Primary Template-directed Amplification (PTA) technology across the Benelux (Netherlands, Belgium, and Luxembourg) and Nordic (Denmark, Norway, Sweden and Finland) regions, effective immediately.

Accurate, uniform and reproducible

BioSkryb’s ResolveDNA provides industry-leading genomic coverage by leveraging novel PTA technology to dramatically increase genomic capture and coverage. The ResolveDNA product line reproduces genomes of single cells to provide high-quality, scalable analysis of single-cell genomic heterogeneity in a more accurate, uniform and reproducible manner than traditional methods.

BioSkryb also has a first of its kind multiomic product, ResolveOME, that enables whole genome and whole transcriptome analysis within each individual cell in an integrated workflow. When coupled with BioSkryb’s BaseJumper™ bioinformatics platform, which provides quick analysis of complex data at scale, investigators can comprehensively explore single cell multiomic data to enhance our understanding of complex diseases.

A deeper understanding of the cellular ecosystem

“Our technology allows for a deeper understanding of the cellular ecosystem and has the potential to transform the way researchers and clinicians understand and treat devastating diseases, such as cancer,” said Suresh Pisharody, CEO of BioSkryb Genomics. “We are excited to work closely with the BIOKÉ team to bring our powerful solutions to a broader network of researchers in the European market.”

“By combining BIOKÉ’s in-depth knowledge of the genomics market space with BioSkryb’s innovative WGA approach,” says Robert Hovingh, Sales Manager Europe BIOKÉ, “this agreement will provide tools to researchers to study genomic heterogeneity and enable the development of new diagnostics for insights into human disease at the cellular level.”

About BioSkryb Genomics
BioSkryb Genomics is a rapidly growing organization that is transforming single cell molecular discovery and analysis. Through its single cell whole genome and whole transcriptome amplification tools, scientists and clinicians can gain an unprecedented view of the genome, transcriptome, and proteome within a single cell to better understand the drivers, mechanisms, and management of complex disease. The company is headquartered in Durham, North Carolina. For more information, visit our website.

About BIOKÉ
Founded in 2004, BIOKÉ is an experienced and knowledgeable company that provides innovative products with the highest quality in the life science industry throughout Europe. BIOKÉ delivers unique and high-performance products for genomics, protein analysis and cell biology. In July 2009 Cell Signaling Technology, Inc. (CST) acquired BIOKÉ BV and BIOKÉ became a business unit of Cell Signaling Technology. BIOKÉ holds offices in Leiden, the Netherlands. For additional information please visit the website.

Written by

BIOKÉ

BIOKÉ delivers unique and high-performance applications and workflows for genomics, protein analysis and cell biology. Our team of professionals is carefully selected to form a company which has everything to... Read more